RATIONALE: The metabolic activity of the tongue is unknown in patients with obstructive sleep apnea (OSA). Tongue electromyographic (EMG) activity is increased in patients with OSA. This increase in tongue EMG activity is thought to be related to either increased neuromuscular compensation or denervation with subsequent reinnervation of the muscle fibers. Increased glucose uptake in the tongue would support increased neuromuscular compensation, whereas decreased glucose uptake in the tongue would support denervation with subsequent reinnervation of the muscle fibers. OBJECTIVES: To investigate the metabolic activity of the genioglossus and control upper airway muscles in obese patients with sleep apnea compared with obese control subjects. METHODS: Obese subjects with and without OSA underwent a standard overnight sleep study to determine an apnea-hypopnea index. Each subject had a positron emission tomography with [(18)F]-2-fluoro-2-deoxy-D-glucose scan in addition to noncontrast computed tomography or magnetic resonance imaging. Glucose uptake was quantified within upper airway tissues with the standardized uptake value. MEASUREMENTS AND MAIN RESULTS: We recruited 30 obese control subjects (apnea-hypopnea index, 4.7 ± 3.1 events per hour) and 72 obese patients with sleep apnea (apnea-hypopnea index, 43.5 ± 28.0 events per hour). Independent of age, body mass index, sex, and race, patients with OSA had significantly reduced glucose uptake in the genioglossus (P = 0.03) in comparison with obese normal subjects. No differences in standardized uptake value were found in the control muscles (masseter [P = 0.38] and pterygoid [P = 0.70]) and subcutaneous fat deposits (neck [P = 0.44] and submental [P = 0.95]) between patients with OSA and control subjects. CONCLUSIONS: There was significantly reduced glucose uptake in the genioglossus of patients with sleep apnea in comparison with obese normal subjects with [(18)F]-2-fluoro-2-deoxy-D-glucose positron emission tomography imaging. The reduction in glucose uptake was likely secondary to alterations in tongue muscle fiber-type or secondary to chronic denervation. The reduced glucose uptake argues against the neuromuscular compensation hypothesis explaining the increase in tongue EMG activity in obese patients with OSA.
RATIONALE: The metabolic activity of the tongue is unknown in patients with obstructive sleep apnea (OSA). Tongue electromyographic (EMG) activity is increased in patients with OSA. This increase in tongue EMG activity is thought to be related to either increased neuromuscular compensation or denervation with subsequent reinnervation of the muscle fibers. Increased glucose uptake in the tongue would support increased neuromuscular compensation, whereas decreased glucose uptake in the tongue would support denervation with subsequent reinnervation of the muscle fibers. OBJECTIVES: To investigate the metabolic activity of the genioglossus and control upper airway muscles in obesepatients with sleep apnea compared with obese control subjects. METHODS:Obese subjects with and without OSA underwent a standard overnight sleep study to determine an apnea-hypopnea index. Each subject had a positron emission tomography with [(18)F]-2-fluoro-2-deoxy-D-glucose scan in addition to noncontrast computed tomography or magnetic resonance imaging. Glucose uptake was quantified within upper airway tissues with the standardized uptake value. MEASUREMENTS AND MAIN RESULTS: We recruited 30 obese control subjects (apnea-hypopnea index, 4.7 ± 3.1 events per hour) and 72 obesepatients with sleep apnea (apnea-hypopnea index, 43.5 ± 28.0 events per hour). Independent of age, body mass index, sex, and race, patients with OSA had significantly reduced glucose uptake in the genioglossus (P = 0.03) in comparison with obese normal subjects. No differences in standardized uptake value were found in the control muscles (masseter [P = 0.38] and pterygoid [P = 0.70]) and subcutaneous fat deposits (neck [P = 0.44] and submental [P = 0.95]) between patients with OSA and control subjects. CONCLUSIONS: There was significantly reduced glucose uptake in the genioglossus of patients with sleep apnea in comparison with obese normal subjects with [(18)F]-2-fluoro-2-deoxy-D-glucose positron emission tomography imaging. The reduction in glucose uptake was likely secondary to alterations in tongue muscle fiber-type or secondary to chronic denervation. The reduced glucose uptake argues against the neuromuscular compensation hypothesis explaining the increase in tongue EMG activity in obesepatients with OSA.
Authors: Toshihiko Fujimoto; Jukka Kemppainen; Kari K Kalliokoski; Pirjo Nuutila; Masatoshi Ito; Juhani Knuuti Journal: Med Sci Sports Exerc Date: 2003-05 Impact factor: 5.411
Authors: Julian P Saboisky; Jane E Butler; Robert B Fogel; Janet L Taylor; John A Trinder; David P White; Simon C Gandevia Journal: J Neurophysiol Date: 2005-11-23 Impact factor: 2.714
Authors: Anh Tu Duy Nguyen; Vincent Jobin; Richard Payne; Josée Beauregard; Naftaly Naor; R John Kimoff Journal: Sleep Date: 2005-05 Impact factor: 5.849
Authors: Robert B Fogel; John Trinder; David P White; Atul Malhotra; Jill Raneri; Karen Schory; Darci Kleverlaan; Robert J Pierce Journal: J Physiol Date: 2005-02-03 Impact factor: 5.182
Authors: Ianessa A Humbert; Scott B Reeder; Eva J Porcaro; Stephanie A Kays; Jean H Brittain; Joanne Robbins Journal: J Magn Reson Imaging Date: 2008-08 Impact factor: 4.813
Authors: Richard J Schwab; Sarah E Leinwand; Cary B Bearn; Greg Maislin; Ramya Bhat Rao; Adithya Nagaraja; Stephen Wang; Brendan T Keenan Journal: Chest Date: 2017-05-17 Impact factor: 9.410
Authors: Ivan R B Godoy; Edgar Leonardo Martinez-Salazar; Alireza Eajazi; Pedro R Genta; Miriam A Bredella; Martin Torriani Journal: Metabolism Date: 2016-09-02 Impact factor: 8.694
Authors: Grace W Pien; Brendan T Keenan; Carole L Marcus; Bethany Staley; Sarah J Ratcliffe; Nicholas J Jackson; William Wieland; Yi Sun; Richard J Schwab Journal: Sleep Date: 2016-05-01 Impact factor: 5.849
Authors: Yuan Feng; Brendan T Keenan; Stephen Wang; Sarah Leinwand; Andrew Wiemken; Allan I Pack; Richard J Schwab Journal: Am J Respir Crit Care Med Date: 2018-12-01 Impact factor: 30.528